ANAPTYSBIO, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2014 | — | — | $22.3M |
| Dec 2015 | — | — | $51.7M |
| Jun 2016 | — | — | $50.6M |
| Sep 2016 | — | — | $47.2M |
| Dec 2016 | $100.4M | $62.2M | $51.2M |
| Mar 2017 | $21.0M | $131.1M | $96.8M |
| Jun 2017 | $21.2M | $130.4M | $30.8M |
| Sep 2017 | $20.6M | $121.9M | $26.7M |
| Dec 2017 | $21.8M | $329.4M | $81.2M |
| Mar 2018 | $20.3M | $314.8M | $69.5M |
| Jun 2018 | $21.0M | $306.0M | $57.1M |
| Sep 2018 | $23.4M | $523.1M | $293.4M |
| Dec 2018 | $22.6M | $509.0M | $113.6M |
| Mar 2019 | $26.1M | $494.2M | $105.9M |
| Jun 2019 | $31.7M | $480.1M | $146.6M |
| Sep 2019 | $30.6M | $451.5M | $182.9M |
| Dec 2019 | $30.2M | $435.2M | $171.0M |
| Mar 2020 | $23.7M | $424.2M | $165.3M |
| Jun 2020 | $20.3M | $401.7M | $221.2M |
| Sep 2020 | $24.5M | $384.8M | $209.2M |
| Dec 2020 | $19.8M | $416.6M | $250.5M |
| Mar 2021 | $14.5M | $396.4M | $284.1M |
| Jun 2021 | $40.8M | $426.6M | $332.3M |
| Sep 2021 | $40.7M | $424.3M | $336.3M |
| Dec 2021 | $286.6M | $643.1M | $495.7M |
| Mar 2022 | $294.4M | $625.2M | $166.4M |
| Jun 2022 | $299.5M | $603.8M | $71.7M |
| Sep 2022 | $340.9M | $618.5M | $58.5M |
| Dec 2022 | $348.3M | $610.4M | $71.3M |
| Mar 2023 | $360.7M | $551.8M | $94.6M |
| Jun 2023 | $368.7M | $517.1M | $35.2M |
| Sep 2023 | $366.9M | $487.3M | $26.3M |
| Dec 2023 | $364.3M | $452.4M | $36.0M |
| Mar 2024 | $358.1M | $405.8M | $53.7M |
| Jun 2024 | $417.5M | $427.4M | $71.8M |
| Sep 2024 | $409.1M | $493.4M | $191.6M |
| Dec 2024 | $413.0M | $483.8M | $123.1M |
| Mar 2025 | $388.0M | $422.1M | $98.6M |
| Jun 2025 | $380.0M | $335.3M | $44.3M |
| Sep 2025 | $382.5M | $353.1M | $109.8M |
| Dec 2025 | $327.2M | $364.4M | $238.2M |
| Mar 2026 | $316.9M | $329.7M | $248.5M |